Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression

Leukemia

Volumn 15, Issue 3, 2001, Pages 406-414

  Tabernero, M D ^a   Bortoluci, A M ^a   Alaejos, I ^b   Lopez Berges M C ^b   Rasillo, A ^a   Garcia Sanz R ^b   Garcia M ^a   Sayagues J M ^a   Gonzalez M ^b   Mateo, G ^b   San Miguel, J F ^b   Orfao, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Inmunophenotype; Patterns of expression; Precursor B ALL; T(9; 22)(q34; q11)

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA; MICROSOMAL AMINOPEPTIDASE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANEUPLOIDY; ARTICLE; B CELL LEUKEMIA; BLAST CELL; CHILD; CHROMOSOME 22Q; CHROMOSOME 9Q; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; PROLYMPHOCYTE; PROTEIN EXPRESSION; RECIPROCAL CHROMOSOME TRANSLOCATION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STAINING;

EID: 0035082733     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402060     Document Type: Article

References (60)

1. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Guiemsa staining
2. Molecular genetics in acute leukaemia
3. The Philadelphia (ph) chromosome in leukemia. II. Variant Ph translocations in acute lymphoblastic leukemia
4. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
5. New type of Bcr/Abl junction in philadelphia chromosome-positive chronic myelogenous leukemia
6. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia
7. Chromosome abnormalities in CML
8. Review: The molecular biology of chronic myelogenous leukemia
9. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia
10. High rate of chromosome abnormalities detected by fluorescence in situ hybridization using BCR and ABL probes in adult acute lymphoblastic leukemia
11. The biology and treatment of acute lymphoblastic leukemia in adults
12. Philadelphia positive acute lymphoblastic leukaemia in adults - Age distribution, BCR breakpoint and prognostic significance
13. Adult Philadelphia-chromosome-positive acute lymphoblastic leukaemia: Experience of treatments during a 10-year period
14. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA
15. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia
16. Acute lymphoblastic leukemia
17. Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic
18. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762)
19. Intensive chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia
20. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
21. Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia
22. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
23. Current management of acute lymphoblastic leukemia in adults
24. Detection of minimal residual disease in acute leukemia: Methodologic advanced and clinical significance
25. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia
26. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: Current status and future directions
27. Residual disease detection of leukemia
28. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: A pediatric oncology group study
29. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: Implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis
30. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: Correlation with specific genotype. ETV6/AML1 ALLs identification
31. Association of CD15 expression and 11q23 translocation in acute leukemias
32. Acute leukemias with the t(4;11)(q21;q23)
33. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse
34. Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL)
35. Acute lymphoblastic leukemia (ALL): Detection of minimal residual disease (MRD) at flow cytometry
36. A new staging system for multiple myeloma based on the number of S-phase plasma cells
37. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
38. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
39. Detection of the Mbcr/abl translocation in chronic myeloid leukaemia by fluorescence in situ hibridization. Comparison with conventional cytogenetics and implications for minimal residual disease detection
40. Incidence of chromosome numerical changes in multiple myeloma. Fluorescence in situ hybridization analysis using 15 chromosome-specific probes
41. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia
42. Consequences of chromosomal abnormalities in tumour development
43. The tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL-2
44. Tyrosine kinase activity and transformation potential of bcr-abl oncogene products
45. Chronic myelogenous leukemia: Too much or too little growth, or both?
46. Phosphatidylinositol - 3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
47. PI 3-kinase activation in BCR/abl transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR/abl
48. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukaemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials CoALL-05-92
49. Expression of CD25 (interleukin-2 receptor alfa chain) in adult acute lymphoblastic leukaemia predicts for the presence of BCR/ABL fusion transcripts: Results of a preliminary laboratory analysis of ECOG/MRC intergroup study E2993
50. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity
51. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts
52. Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukaemia predicts TEL-AML1 negativity
53. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia
54. Flow cytometry analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL
55. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-Rarα gene rearrangements
56. - cells in lymphohematopoiesis
57. - progenitor cells
58. Flow cytometric analysis of human bone marrow. II Normal B lymphocyte-development
59. The 'common stem cell' hypothesis reevaluated: Human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors
60. Inhibition of CD10/neutral endopeptidase 24.11 promotes B-cell reconstitution and maturation in vivo